Badar, Athar A <br/><br/>
Clinical Characteristics and Outcomes of Patients With Coronary Artery Disease and Angina: Analysis of the Irbesartan in Patients With Heart Failure and Preserved Systolic Function Trial.  [electronic resource] 

 -  Circulation. Heart failure  Jul 2015 
 - 717-24 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1941-3297 
<br/><br/><label>Standard No.: </label>10.1161/CIRCHEARTFAILURE.114.002024  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Angina Pectoris--diagnosis<br/>Angiotensin II Type 1 Receptor Blockers--adverse effects<br/>Biphenyl Compounds--adverse effects<br/>Coronary Artery Disease--diagnosis<br/>Death, Sudden, Cardiac--epidemiology<br/>Female<br/>Heart Failure--diagnosis<br/>Humans<br/>Irbesartan<br/>Kaplan-Meier Estimate<br/>Male<br/>Middle Aged<br/>Proportional Hazards Models<br/>Randomized Controlled Trials as Topic<br/>Retrospective Studies<br/>Risk Assessment<br/>Risk Factors<br/>Stroke Volume<br/>Systole<br/>Tetrazoles--adverse effects<br/>Time Factors<br/>Treatment Outcome<br/>Ventricular Function, Left